PMID- 23147524 OWN - NLM STAT- MEDLINE DCOM- 20130227 LR - 20211021 IS - 1572-0241 (Electronic) IS - 0002-9270 (Print) IS - 0002-9270 (Linking) VI - 108 IP - 1 DP - 2013 Jan TI - Helicobacter pylori-negative gastritis: prevalence and risk factors. PG - 65-71 LID - 10.1038/ajg.2012.372 [doi] AB - OBJECTIVES: Recent studies using histology alone in select patients have suggested that Helicobacter pylori-negative gastritis may be common. The objective of this study was to investigate the prevalence of H. pylori among individuals with histologic gastritis. METHODS: Subjects between 40 and 80 years underwent elective esophagogastroduodenoscopy at a VA Medical Center. Gastric biopsies were mapped from seven prespecified sites (two antrum, four corpus, and one cardia) and graded by two gastrointestinal pathologists, using the Updated Sydney System. H. pylori-negative required four criteria: negative triple staining at all seven gastric sites, negative H. pylori culture, negative IgG H. pylori serology, and no previous treatment for H. pylori. Data regarding tobacco smoking, alcohol drinking, nonsteroidal anti-inflammatory drug, and proton pump inhibitor (PPI) use were obtained by questionnaire. RESULTS: Of the 491 individuals enrolled, 40.7% (200) had gastritis of at least grade 2 in at least one biopsy site or grade 1 in at least two sites. Forty-one (20.5%) had H. pylori-negative gastritis; most (30 or 73.2%) had chronic gastritis, five (12.2%) had active gastritis, and six (14.6%) had both. H. pylori-negative gastritis was approximately equally distributed in the antrum, corpus, and both antrum and corpus. Past and current PPI use was more frequent in H. pylori-negative vs. H. pylori-positive gastritis (68.2% and 53.8%; P=0.06). CONCLUSIONS: We used multiple methods to define non-H. pylori gastritis and found it in 21% of patients with histologic gastritis. While PPI use is a potential risk factor, the cause or implications of this entity are not known. FAU - Nordenstedt, Helena AU - Nordenstedt H AD - Houston VA HSR&D Center of Excellence, Houston, TX, USA. FAU - Graham, David Y AU - Graham DY FAU - Kramer, Jennifer R AU - Kramer JR FAU - Rugge, Massimo AU - Rugge M FAU - Verstovsek, Gordana AU - Verstovsek G FAU - Fitzgerald, Stephanie AU - Fitzgerald S FAU - Alsarraj, Abeer AU - Alsarraj A FAU - Shaib, Yasser AU - Shaib Y FAU - Velez, Maria E AU - Velez ME FAU - Abraham, Neena AU - Abraham N FAU - Anand, Bhupinderjit AU - Anand B FAU - Cole, Rhonda AU - Cole R FAU - El-Serag, Hashem B AU - El-Serag HB LA - eng GR - P30 DK056338/DK/NIDDK NIH HHS/United States GR - R01 116845/PHS HHS/United States GR - DK K24-04-107/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20121113 PL - United States TA - Am J Gastroenterol JT - The American journal of gastroenterology JID - 0421030 SB - IM CIN - Am J Gastroenterol. 2013 Jan;108(1):72-4. PMID: 23287944 MH - Adult MH - Aged MH - Aged, 80 and over MH - Biopsy MH - Cross-Sectional Studies MH - Endoscopy, Digestive System MH - Female MH - Gastric Mucosa/microbiology/pathology MH - Gastritis/epidemiology/*etiology/microbiology/pathology MH - Health Surveys MH - Helicobacter Infections/*complications/epidemiology/pathology MH - Helicobacter pylori/*isolation & purification MH - Humans MH - Logistic Models MH - Male MH - Middle Aged MH - Multivariate Analysis MH - Prevalence MH - Risk Factors MH - Surveys and Questionnaires MH - Texas/epidemiology PMC - PMC3984401 MID - NIHMS564483 COIS- Potential competing interests: None. EDAT- 2012/11/14 06:00 MHDA- 2013/02/28 06:00 PMCR- 2014/04/12 CRDT- 2012/11/14 06:00 PHST- 2012/11/14 06:00 [entrez] PHST- 2012/11/14 06:00 [pubmed] PHST- 2013/02/28 06:00 [medline] PHST- 2014/04/12 00:00 [pmc-release] AID - ajg2012372 [pii] AID - 10.1038/ajg.2012.372 [doi] PST - ppublish SO - Am J Gastroenterol. 2013 Jan;108(1):65-71. doi: 10.1038/ajg.2012.372. Epub 2012 Nov 13.